Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Puerto Rico Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20054
20066
20074
20085
20098
20105
20115
20123
20133
20145
20164
20175
20203
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Terminated5
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S32
AstraZeneca12
Eli Lilly and Company9
Takeda3
Bristol-Myers Squibb2
Janssen Research & Development, LLC2
Kodiak Sciences Inc2
Pfizer2
Generex Biotechnology Corp.1
Kailera1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus68
Diabetes Mellitus, Type 252
Glucose Metabolism Disorders8
Metabolic Diseases7
Endocrine System Diseases6
Diabetes Mellitus, Type 15
Diabetic Retinopathy2
Eye Diseases2
Insulin Resistance2
Macular Edema2

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.